The well-established causative role of low-density lipoprotein particles in atherosclerotic plaque development has led to this biomarker being a primary target of treatment in the prevention of coronary artery disease.
Peter H. Jones, MD, is associate professor, Center for Cardiovascular Disease Prevention, Baylor College of Medicine, Houston, TX.
Advertisement
Articles by Peter H. Jones, MD, is associate professor, Center for Cardiovascular Disease Prevention, Baylor College of Medicine, Houston, TX.
Advertisement
Latest Updated Articles
- Lipoprotein(a) and coronary artery disease:
September 2nd 2008
Advertisement
Advertisement
Trending on HCPLive
1
Screening and Diagnosis of Hypercortisolism in Type 2 Diabetes
2
Prevalence and Recognition of Hypercortisolism
3
Distinguishing CSU From Chronic Inducible Urticaria Subtypes
4
Diagnosing the Hallmark Signs and Symptoms of CSU
5